`Proven record for safety`: Bharat Biotech after Covaxin gets emergency usage nod for kids above 12 years

"Covaxin has established a proven record for safety and efficacy in adults for the original variant and subsequent variants. We have documented excellent safety and immunogenicity data readouts in Children," Bharat Biotech said.